Lisberg A, Huppert LA, Halmos B, Ledezma B, et al. Datopotamab deruxtecan-associated select adverse events: clinical practices and institutional protocols on prophylaxis, monitoring, and management. Oncologist 2025;30:oyaf225.
PMID: 40700616